Relationship of Biochemical Outcome to Percentage of Positive Biopsies in Men with Clinically Localized Prostate Cancer Treated with Permanent Interstitial Brachytherapy

Urology

Volumn 71, Issue 4, 2008, Pages 723-727

  Guzzo, Thomas J ^a   Levin, Brian M ^a   Lee, Richard ^a   Guo, Mengye ^b   Chen, Zhen ^b   Whittington, Richard ^a   Tomaszewski, John ^a   Malkowicz, S Bruce ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER RISK; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BRACHYTHERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 41149144325     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.09.027     Document Type: Article

References (17)

1. Galper S.L., Chen M.H., Catalona W.J., et al. Evidence to support a continued stage migration and decrease in prostate cancer specific mortality. J Urol 175 (2006) 907-912
2. Jang T.L., Han M., Roehl K.A., et al. More favorable tumor features and progression-free survival rates in a longitudinal prostate cancer screening study: PSA era and threshold-specific effects. Urology 67 (2006) 343-348
3. Zebic N., Roggenbuck U., Mandt D., et al. Migration in clinical and pathological stage of prostatic carcinoma in patients undergoing radical prostatectomy in the period between 1993 and 2003. Coll Anthropol 29 (2005) 593-598
4. Paquette E.L., Sun L., Paquette L.R., et al. Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing. Urology 60 (2002) 756-759
5. Merrick G.S., Butler W.M., Wallner K.E., et al. Monotherapeutic brachytherapy for clinically organ-confined prostate cancer. WV Med J 101 (2005) 168-171
6. Han M., Partin A.W., Pound C.R., et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy: the 15-year Johns Hopkins experience. Urol Clin North Am 28 (2001) 555-565
7. Pisansky T.M. External beam radiotherapy as curative treatment of prostate cancer. Mayo Clin Proc 80 (2005) 883-898
8. Beyer D.C., Thomas T., Hilbe J., et al. Relative influence of Gleason score and pretreatment PSA in predicting survival following brachytherapy for prostate cancer. Brachytherapy 2 (2003) 77-84
9. Tigrani V.S., Bhargava V., Shinohara K., et al. Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy. Urology 54 (1999) 689-693
10. Goto Y., Ohori M., and Scardino P.T. Use of systematic biopsy results to predict pathologic stage in patients with clinically localized prostate cancer: a preliminary report. Int J Urol 5 (1998) 337-342
11. Gao X., Mohideen N., Flanigan R.C., et al. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection. J Urol 164 (2000) 1982-1986
12. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Clinical utility of the percentage of positive biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol 18 (2000) 1164-1172
13. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 95 (2002) 281-286
14. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Investigating the clinical utility of the percent of positive prostate biopsies in predicting PSA outcome following local therapy for patients with clinically localized prostate cancer. Prostate Cancer Prostatic Dis 4 (2000) 259-264
15. McMullen K.P., and Lee W.R. A structured literature review to determine the use of the American Society for Therapeutic Radiology and Oncology consensus definition of biochemical failure. Urology 61 (2003) 391-396
16. Merrick G.S., Butler W.M., Wallner K.E., et al. Prognostic significance of percent positive biopsies in clinically organ-confined prostate cancer treated with permanent prostate brachytherapy with or without supplemental external beam radiation. Can J 10 (2004) 54-60
17. Lotan Y., Shariat S.F., Khoddami S.M., et al. The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy. J Urol 171 (2004) 2209-2214